Stop me if you’ve heard this one before: an entrepreneur comes to the United States from her home country with dreams of growing an idea into a blockbuster company. The entrepreneur starts the company here because of our culture of innovation and risk-taking, coupled with robust financing options and the world’s best universities. Working shoulder-to-shoulder […]
It has been one week since the venture capital community convened in Washington, D.C. at the 2017 NVCA Annual Meeting and everyone is still buzzing from the event and our new format. We rewrote the script for this year’s event to focus exclusively on policy and direct engagement with policymakers to advance a pro-innovation agenda […]
Thirty years ago, the median time for the Food and Drug Administration (FDA) approval of a new drug was 33 months. As one can imagine, major backlog at the agency caused significant delay to the approval and entry of potentially life-saving drugs in the market. To address this problem, Congress passed the Prescription Drug User […]
Like you, we have had time to digest the executive order “Protecting the Nation From Foreign Terrorist Entry Into the United States” issued by President Trump last Friday. Under the order, the president indefinitely barred Syrian refugees from entering the U.S., implemented a hold on all refugee admission for 120 days and blocked entry of […]
The last few weeks of 2016 have been an active time in policymaking that had a positive impact on the venture capital industry. NVCA kept its on eye on the ball on behalf of the venture industry and as a result came away with several key victories. After a multi-year, bipartisan effort, the 21st Century […]
The 2016 election was one of the most surprising elections in recent memory, as Donald Trump defeated Hillary Clinton in the presidential election and the Republican party maintained their majorities in both the House and the Senate. As we do after every election, NVCA provided an election analysis to our membership. We took a look […]
Venture capital’s contribution to the technology and Internet sectors are well understood, with VC partnering with the founders of iconic brands like Facebook, Uber, and Netflix. What is not as well understood is how venture is tackling the world’s deadliest diseases and afflictions through the patient investment of capital in life science startups. A prominent […]
At NVCA we are committed to helping policymakers craft pro-growth policies that help startups continue to drive the U.S. economy and encourage job creation. So when we see articles that fail to understand how innovation and entrepreneurship work, it is our responsibility to correct the record. This recent article in Politico makes just this mistake […]
The Chamber of Commerce today kicked off the 10th Annual Capital Markets Summit in Washington, DC. The event is a widely attended affair and a great opportunity to bring together lawmakers, regulators, market participants and observers alike to discuss the state of our capital markets.
The venture capital ecosystem has deployed over $10 billion to cybersecurity companies since 2012. As the frequency and severity of cyber-attacks increase unabated, venture investment into cybersecurity startups will continue to grow, placing venture capitalists and the entrepreneurs they support on the frontlines of our country’s cyber defense capabilities.